TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds September 26, 2003
TCL Archive ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says. July 28, 2006
TCL Archive NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open March 9, 1979